Cardiovascular Risk Higher With Allopurinol vs Benzbromarone in Patients With Gout
Researchers compared cardiovascular risk among patients with gout who received treatment with allopurinol vs benzbromarone.
Gout
Metagenomic Analysis Shows That the Gut Microbiome May Have a Role in Gout
Researchers of a metagenomic analysis assessed the taxonomic and functional signatures of the gut microbiome in gout and its association with clinical parameters and response to therapeutic interventions.
No Difference Between Early and Late Allopurinol Initiation for Acute Gout Flare
Researchers compared the time to complete resolution of acute gout flare between early and late allopurinol initiation.
Consensus Statement on Research Priorities for the Management of Gout in Chronic Kidney Disease
A consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) included key areas for research to address challenges in the management of gout in patients with chronic kidney disease.
Gout Prevalence Is Increasing Among US Veterans
Gout prevalence in Veterans Affairs medical centers increased from 4.2% in 2005 to 5.8% in 2014.
Single Urate Measurements Unreliable for Hyperuricemia Classification
Consistent with previous studies, investigators documented variation in serum urate levels over time.
Hyperuricemia Is a Risk Factor for ESKD in Minimal Change Disease
This study is the first to find an association between hyperuricemia and MCD progression in adults.
Urate-Lowering Therapies for Hyperuricemia in CKD Not Renoprotective
Investigators examined the urate-lowering effects of febuxostat, allopurinol, and benzbromarone and their association with renal protection in CKD.
Evidence-Based Strategies Needed to Improve Outcomes for Patients Hospitalized With Gout – An Interview With Dr Brian LaMoreaux
In an interview, Brian LaMoreaux, MD, MS, discusses the need for evidence-based strategies to improve outcomes for patients hospitalized with gout.
Novel Risk Stratification Tool Identifies Patients at High Risk for Inpatient Gout Flare
Researchers developed and validated a gout flare risk stratification tool for patients with gout who were hospitalized for nongout conditions.
- Loading...
Loading...
Next post in Hyperuricemia
Loading... 
Loading...